STOCK TITAN

ASLAN Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

ASLAN Pharmaceuticals (Nasdaq: ASLN) announced participation by CEO Dr. Carl Firth in two virtual health conferences. The first, the Piper Sandler 33rd Annual Virtual Healthcare Conference, will feature a recorded discussion available on November 22, 2021, at 10:00 am ET. The second event is the 4th Annual Evercore ISI HealthCONx Conference, scheduled for December 2, 2021, at 8:50 am ET, located in Track 3. Both discussions can be accessed later on ASLAN's Investor Relations website.

Positive
  • None.
Negative
  • None.

MENLO PARK, Calif. and SINGAPORE, Nov. 22, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that Dr Carl Firth, CEO, will be participating in fireside chats at two upcoming virtual health conferences. The details are as follows:

Piper Sandler 33rd Annual Virtual Healthcare Conference

  • Recorded discussion available: November 22, 2021, at 10:00 am ET

4th Annual Evercore ISI HealthCONx Conference

  • Date and time: Thursday, December 2, 2021, at 8:50 am ET
  • Location: Track 3

Both discussions will be accessible afterwards within the News & Events section of ASLAN’s Investor Relations website at https://ir.aslanpharma.com/.

Media and IR contacts

Emma Thompson
Spurwing Communications
Tel: +65 6206 7350
Email: ASLAN@spurwingcomms.com

Ashley R. Robinson
LifeSci Advisors, LLC
Tel: +1 (617) 430-7577
Email: arr@lifesciadvisors.com

About ASLAN Pharmaceuticals
ASLAN Pharmaceuticals (Nasdaq: ASLN) is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is currently evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease. ASLAN has a team in Menlo Park, California, and in Singapore. For additional information please visit www.aslanpharma.com or follow ASLAN on LinkedIn.


FAQ

What is ASLAN Pharmaceuticals' stock symbol?

ASLAN Pharmaceuticals is traded under the stock symbol ASLN.

When is Dr. Carl Firth speaking at the Piper Sandler conference?

Dr. Carl Firth's recorded discussion at the Piper Sandler conference will be available on November 22, 2021, at 10:00 am ET.

When will the 4th Annual Evercore ISI HealthCONx Conference take place?

The 4th Annual Evercore ISI HealthCONx Conference will occur on December 2, 2021, at 8:50 am ET.

Where can I access the discussions from the health conferences?

The discussions from both conferences will be available in the News & Events section of ASLAN's Investor Relations website.

ASLAN Pharmaceuticals Limited American Depositary Shares

NASDAQ:ASLN

ASLN Rankings

ASLN Latest News

ASLN Stock Data

1.70M
565.67M
0.14%
13.21%
1.35%
Biotechnology
Healthcare
Link
United States of America
Singapore